A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 25 Jul 2018
At a glance
- Drugs Ascorbic acid (Primary) ; Temozolomide
- Indications Glioblastoma
- Focus Adverse reactions; First in man
- 09 May 2018 Planned End Date changed from 1 Mar 2017 to 31 Dec 2021.
- 17 Dec 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 01 Apr 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.